Insulin Degludec
NDC 73070-400, insulin degludec, injection, solution, from Novo Nordisk Pharma, Inc..
- Product NDC
- 73070-400
- Status
- Listed
- Labeler
- Novo Nordisk Pharma, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA203314
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73070-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN DEGLUDEC100 U/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73070-400-11 | 73070040011 | 1 VIAL, GLASS in 1 CARTON (73070-400-11) / 10 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c1be283d-4b1d-4996-b2a7-4488dbff3037NADAC price for package 73070040011
GET /v1/drugs/nadac/73070040011
Use it
Look up 73070-400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73070-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73070-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.